Related Experiment Video
Updated: Aug 10, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Proteomic analysis of childhood leukemia
C M Hegedus1, L Gunn, C F Skibola
1Molecular Epidemiology and Toxicology Laboratory, School of Public Health, University of California, Berkeley, CA 94720-7360, USA.
Leukemia
|September 2, 2005
Summary
Proteome analysis can distinguish between childhood leukemia subtypes, identifying differentially expressed proteins including a truncated ubiquitin. This technique offers potential for improved leukemia classification and targeted therapies.
Area of Science:
- Biochemistry
- Oncology
- Proteomics
Background:
- Childhood leukemias are classified into molecular and cytogenetic subgroups impacting prognosis and therapy.
- Gene expression profiling is established for discriminating leukemia subtypes.
- Proteome analysis presents a promising avenue for characterizing distinct childhood leukemia subtypes.
Purpose of the Study:
- To investigate the potential of proteome analysis in differentiating childhood leukemia subtypes.
- To identify differentially expressed proteins in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) cases.
- To explore specific protein markers for leukemia subclassification.
Main Methods:
- Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) was employed.
- Analysis was performed on cell lysates from childhood leukemia cell lines (Kasumi, MV4;11, 697, REH).
- Pretreatment leukemic bone marrow samples from childhood leukemia patients were analyzed.
Main Results:
- Proteomic profiles differentiated between AML and ALL cell lines, revealing numerous differentially expressed proteins.
- A specific 8.3 kDa protein, identified as C-terminal truncated ubiquitin, was differentially expressed.
- Analysis of bone marrow samples showed distinct protein profiles between AML and ALL, and between ALL subtypes (t(12;21) and hyperdiploid).
Conclusions:
- Proteome analysis demonstrates significant potential for distinguishing various forms of childhood leukemia.
- The findings suggest that proteomic profiling can aid in classifying leukemia subtypes.
- Further research is needed to validate these proteomic findings and explore the role of truncated ubiquitin in ALL etiology.
